Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PBHC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Joseph Polniak FVP, General Counsel | PBHC Pathfinder Bancorp, Inc. | Buy | 1,000 | $15.88 | $15.9K Buy | Form 4 ↗ |
| Jun 2, 2026 | James A. Dowd President and CEO | PBHC Pathfinder Bancorp, Inc. | Buy | 1,400 | $13.69 | $19.2K Buy | Form 4 ↗ |
| Feb 13, 2026 | Adam C. Gagas Director | PBHC Pathfinder Bancorp, Inc. | Buy | 1,950 | $13.75 | $26.8K Buy | Form 4 ↗ |
| Feb 12, 2026 | Adam C. Gagas Director | PBHC Pathfinder Bancorp, Inc. | Buy | 6 | $13.50 | $81 Buy | Form 4 ↗ |
| Feb 4, 2026 | David A. Ayoub Director | PBHC Pathfinder Bancorp, Inc. | Buy | 425 | $12.83 | $5,453 Buy | Form 4 ↗ |
| May 5, 2025 | David A. Ayoub Director | PBHC Pathfinder Bancorp, Inc. | Buy | 1,000 | $14.95 | $14.9K Buy | Form 4 ↗ |
| Mar 3, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 134 | $17.10 | $2,291 Sale | Form 4 ↗ |
| Feb 28, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 2 | $17.10 | $34.2 Sale | Form 4 ↗ |
| Feb 27, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 42 | $17.10 | $718 Sale | Form 4 ↗ |
| Feb 26, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 7 | $17.25 | $121 Sale | Form 4/A ↗ |
| Feb 26, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 1,221 | $17.10 | $20.9K Sale | Form 4/A ↗ |
| Feb 25, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 7 | $17.25 | $121 Sale | Form 4 ↗ |
| Feb 25, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 62 | $17.10 | $1,060 Sale | Form 4 ↗ |
| Feb 20, 2025 | Ronald Tascarella Retired Executive Vice Pres. | PBHC Pathfinder Bancorp, Inc. | Sale | 5,000 | $17.00 | $85.0K Sale | Form 4 ↗ |
| Feb 12, 2025 | William D. O'Brien Senior Vice President | PBHC Pathfinder Bancorp, Inc. | Sale | 2,353 | $17.14 | $40.3K Sale | Form 4 ↗ |
| Dec 3, 2024 | Eric Allyn Director | PBHC Pathfinder Bancorp, Inc. | Sale | 1,014 | $17.28 | $17.5K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:09 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances